SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-079974
Filing Date
2022-07-15
Accepted
2022-07-15 06:03:41
Documents
14
Period of Report
2022-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221127d1_8k.htm   iXBRL 8-K 30998
2 EXHIBIT 99.1 tm2221127d1_ex99-1.htm EX-99.1 12475
3 GRAPHIC tm2221127d1_ex99-1img001.jpg GRAPHIC 7954
  Complete submission text file 0001104659-22-079974.txt   232379

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA swtx-20220714.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20220714_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20220714_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2221127d1_8k_htm.xml XML 3497
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 221084206
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences